Published in Intensive Care Med on August 14, 2012
Acute Kidney Injury Is Common in Pediatric Severe Malaria and Is Associated With Increased Mortality. Open Forum Infect Dis (2016) 0.79
Disease-associated QT-shortage versus quinine associated QT-prolongation: age dependent ECG-effects in Ghanaian children with severe malaria. Malar J (2014) 0.79
Year in review in Intensive Care Medicine 2012: III. Noninvasive ventilation, monitoring and patient-ventilator interactions, acute respiratory distress syndrome, sedation, paediatrics and miscellanea. Intensive Care Med (2013) 0.78
The effect of malaria and anti-malarial drugs on skeletal and cardiac muscles. Malar J (2016) 0.75
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med (2011) 8.55
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med (2005) 7.04
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92
GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med (2013) 3.37
Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol (2008) 2.65
Evaluating health research capacity building: an evidence-based tool. PLoS Med (2006) 2.58
A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology (2012) 2.46
Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A (2006) 2.31
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain (2005) 2.17
Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med (2004) 2.16
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol (2012) 2.05
Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome). Nat Genet (2005) 2.04
Evaluation of a learner-designed course for teaching health research skills in Ghana. BMC Med Educ (2007) 2.02
Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis (2004) 1.99
Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci U S A (2005) 1.95
A prospective comparison of malaria with other severe diseases in African children: prognosis and optimization of management. Clin Infect Dis (2003) 1.93
Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis (2007) 1.93
Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum Mol Genet (2012) 1.90
Malaria, anemia, and malnutrition in african children--defining intervention priorities. J Infect Dis (2006) 1.90
Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage (2007) 1.88
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana. Antimicrob Agents Chemother (2007) 1.82
Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis (2014) 1.80
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ (2004) 1.74
Manifestation and outcome of severe malaria in children in northern Ghana. Am J Trop Med Hyg (2004) 1.71
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children. PLoS One (2009) 1.65
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62
Capillary refill time as an independent prognostic indicator in severe and complicated malaria. J Pediatr (2006) 1.62
Indicators of sustainable capacity building for health research: analysis of four African case studies. Health Res Policy Syst (2011) 1.62
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. Emerg Infect Dis (2009) 1.61
Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann Neurol (2005) 1.56
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr (2006) 1.53
Alpha(+)-thalassemia protects African children from severe malaria. Blood (2004) 1.52
Genome-wide association study indicates two novel resistance loci for severe malaria. Nature (2012) 1.52
The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology (2013) 1.48
Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study. Clin Infect Dis (2013) 1.46
Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop Med Int Health (2005) 1.46
Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T. Magn Reson Imaging (2005) 1.45
Marathon run under chemotherapy: is it possible? Onkologie (2011) 1.40
Ross-Konno procedure in infants: mid-term results. Eur J Cardiothorac Surg (2012) 1.39
A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Trop Med Int Health (2005) 1.31
Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol (2009) 1.29
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc Natl Acad Sci U S A (2008) 1.27
Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis. Malar J (2013) 1.26
Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol (2011) 1.25
Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J (2012) 1.25
Nonrigid registration of multiple sclerosis brain images using lesion inpainting for morphometry or lesion mapping. Hum Brain Mapp (2009) 1.25
Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am J Hum Genet (2003) 1.25
Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci (2009) 1.20
Hemoglobin C and resistance to severe malaria in Ghanaian children. J Infect Dis (2004) 1.20
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol (2012) 1.18
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler (2012) 1.16
Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. Emerg Infect Dis (2014) 1.15
Multislice brain myelin water fractions at 3T in multiple sclerosis. J Neuroimaging (2007) 1.15
Regulation of pacing strategy during athletic competition. PLoS One (2011) 1.15
Exploring the relationship between chronic undernutrition and asymptomatic malaria in Ghanaian children. Malar J (2010) 1.15
TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T. Neuroimage (2006) 1.11
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. Malar J (2011) 1.11
Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. Hum Mol Genet (2010) 1.11
Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency. Trop Med Int Health (2003) 1.10
Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2014) 1.10
Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest (2002) 1.10
High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patients. J Neuroimaging (2009) 1.09
Treatment of imported severe malaria with artesunate instead of quinine--more evidence needed? Malar J (2011) 1.08
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine. BMC Med (2014) 1.07
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain (2010) 1.06
Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med (2015) 1.06
Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice. Nat Med (2011) 1.06
Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. Am J Hum Genet (2004) 1.06
Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol (2007) 1.06
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med (2011) 1.06
Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children. J Clin Pharmacol (2003) 1.05
T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children. PLoS One (2011) 1.04
A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun (2006) 1.04
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas. Eur J Nucl Med Mol Imaging (2015) 1.03
Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS One (2011) 1.02
Limited influence of haptoglobin genotypes on severe malaria in Ghanaian children. Trop Med Int Health (2005) 1.02
Metric optimization for surface analysis in the Laplace-Beltrami embedding space. IEEE Trans Med Imaging (2014) 1.02